ARKG

ARK Genomic Revolution ETF

$46.70

-2.54 (-5.16%)

AUM $2.22B

Expense Ratio 0.75%

NAV $46.64

Holdings 10

Asset Class Equity

Inception 10/31/2014

Provider ARK

Top Holdings

1 TXG 10X GENOMICS INC-CLASS A 8.63% 2 TEM TEMPUS AI INC-CL A 8.03% 3 TWST TWIST BIOSCIENCE CORP 7.73% 4 CRSP CRISPR THERAPEUTICS AG 5.47% 5 NTRA NATERA INC 4.90% 6 ILMN ILLUMINA INC 4.90% 7 GH GUARDANT HEALTH INC 4.82% 8 ABSI ABSCI CORP 4.41% 9 LLY ELI LILLY & CO 4.14% 10 CDNA CAREDX INC 3.62%

Fund Description

The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.